Krsnaa Diagnostics Limited

67 Million

RI Centres 117 Pathology Labs 3,500+ Patient Collection Centres 18 States/ UT Presence in India 67 Million+ Patients Served Since Inception Krsnaa Diagnostics is one of the fastest growing and differentia

rs 2

athologists, and over 3,000 qualified professionals, including clinicians, technicians and operators 2 Krsnaa Diagnostics Financial- At a Glance FY25 Financial Performance INR in mn except EPS, NABL &

16%

FY25 FY24 Growth Particulars FY25 FY24 Growth Revenue 7,172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No.

34%

5 FY24 Growth Particulars FY25 FY24 Growth Revenue 7,172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Pa

27%

ticulars FY25 FY24 Growth Revenue 7,172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No.

24%

ars FY25 FY24 Growth Revenue 7,172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Te

370 bps

FY25 FY24 Growth Revenue 7,172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Test perfo

11%

172 6,196 EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Test performed NABL Accreditation

9%

EBIDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Test performed NABL Accreditation NABH Acc

37%

IDTA 1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Test performed NABL Accreditation NABH Accredit

165 bps

1,958 1,466 16% 34% EBIDTA Margin 27% 24% 370 bps PAT PAT Margin 776 11% 568 9% 37% 165 bps EPS No. of Patient Served No. of Test performed NABL Accreditation NABH Accreditation 23

36%

erformed NABL Accreditation NABH Accreditation 23.6 19.2 61 51 31 17.3 15.6 44 21 22 36% 23% 38% 143% 41% • Achieving 16% YoY Revenue Growth, 34% YoY EBITDA Strengthening & 37% YoY im

“Maturity is on the basis of the project start date 3.”

Notes

1

For further information please contact

1

Notes

1. Net Block % is calculated as on the year ended 31st March 2025 2. Maturity is on the basis of the project start date 3. Return on Capital Employed calculated as (EBIT including Other Income / (Total Asset - Current Liabilities)) 26 Consolidated Financial Performance Krsnaa Diagnostics Financial- At a Glance Particulars Q4 FY 25 Q3 FY 25 Q4 FY 24 FY 25 FY 24 Amount % Amount % Amount % Amount % Amount % In mn Revenue from operations 1,861 Expenses Cost of Material Consumed Employee benefits expense Fees to hospitals and others Other expenses Total Expenses EBITDA Before CSR & ESOP CSR and ESOP EBITDA Less: Finance costs Less: Depreciation Add: Other income PBT Tax PAT 415 320 174 410 1,319 542 12 530 68 220 44 286 79 207 22% 17% 9% 22% 71% 29% 1% 29% 4% 12% 2% 15% 4% 11% 1,745 399 348 136 397 1,280 466 15 451 61 227 92 255 61 194 1,663 430 324 94 374 1,222 441 4 437 73 181 43 226 39 187 23% 20% 8% 23% 73% 27% 1% 26% 4% 13% 5% 15% 4% 11% 26% 19% 6% 22% 73% 27% 0% 26% 4% 11% 3% 14% 2% 1

For further information please contact

Krsnaa Diagnostics Vivek Jain, Investor Relation Head head.investor@krsnaa.in Contact: +91 74107 00645 29